TriOn Pharma Must Face Trial Over Inhaler IP Claims
A London pharmaceutical company lost its bid Friday to toss out a malicious falsehood claim from a medical device manufacturer, with a judge finding the allegations are not time-barred and will...To view the full article, register now.
Already a subscriber? Click here to view full article